Skip to main content
Premium Trial:

Request an Annual Quote

It'll Be Worth the Wait

San Diego's Scripps Translational Science Institute will conduct the first study to assess whether people taking genetic tests will change their behavior, says this article in SciAm. Scripps will offer its 10,000 employees, family members, and friends of the nonprofit Scripps Health system Navigenics' genetic test, and changes in behavior will be assessed over a 20-year period. The study will be led by Eric Topol, director at Scripps.

The Scan

Could Cost Billions

NBC News reports that the new Alzheimer's disease drug from Biogen could cost Medicare in the US billions of dollars.

Not Quite Sent

The Biden Administration likely won't meet its goal of sending 80 million SARS-CoV-2 vaccine doses abroad by the end of the month, according to the Washington Post.

DTC Regulation Proposals

A new report calls on UK policymakers to review direct-to-consumer genetic testing regulations, the Independent reports.

PNAS Papers on Mosquito MicroRNAs, Acute Kidney Injury, Trichothiodystrophy

In PNAS this week: microRNAs involved in Aedes aegypti reproduction, proximal tubule cell response to kidney injury, and more.